
Opinion|Videos|May 27, 2026
Takeaways about bispecific antibodies
Author(s)C. Brooke Adams, Pharm.D., BCOP
Bispecific antibodies are a major advance in multiple myeloma treatment with outstanding efficacy, with many clinical trials underway that are providing the evidence for using them in earlier lines of treatments.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
Loss of copay assistance linked to worse outcomes in retina patients | ASRS 2026
3
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
4
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
5
























